IL-33 is mainly secreted by the airway epithelium and evidenced to exacerbate the Th2-mediated inflammation via further promoting the secretion of IL-4, IL-5, and IL-13 in allergic patients with asthma [39]. This evidence concerns the gene IL13 and asthma.